ID: ALA285952

Max Phase: Preclinical

Molecular Formula: C9H11O7P

Molecular Weight: 262.15

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(O)c1cc(O)c(O)c(CCP(=O)(O)O)c1

Standard InChI:  InChI=1S/C9H11O7P/c10-7-4-6(9(12)13)3-5(8(7)11)1-2-17(14,15)16/h3-4,10-11H,1-2H2,(H,12,13)(H2,14,15,16)

Standard InChI Key:  RPEHOQPIOJRIRA-UHFFFAOYSA-N

Associated Targets(non-human)

aroB 3-dehydroquinate synthase (25 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 262.15Molecular Weight (Monoisotopic): 262.0242AlogP: 0.52#Rotatable Bonds: 4
Polar Surface Area: 135.29Molecular Species: ACIDHBA: 4HBD: 5
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 5#RO5 Violations (Lipinski): 0
CX Acidic pKa: 1.80CX Basic pKa: CX LogP: -0.17CX LogD: -5.63
Aromatic Rings: 1Heavy Atoms: 17QED Weighted: 0.39Np Likeness Score: 0.96

References

1. Chandran SS, Frost JW..  (2001)  Aromatic inhibitors of dehydroquinate synthase: synthesis, evaluation and implications for gallic acid biosynthesis.,  11  (12): [PMID:11412967] [10.1016/s0960-894x(01)00065-8]

Source